Tag Archives: Regulatory

Overcoming Regulatory Risks and Gaining Critical Insights through Social Media Listening

The pharmaceutical industry as a whole has struggled to delve into the social media world. The main reason for this is due to regulatory restrictions, with organizations fearful to engage in online conversations with patients due to the perceived high

Pharma Companies Feeling the Heat From the Sunshine Act

Last week marked the release of the initial data from the Sunshine Act law of the Affordable Care Act, which had been dreaded by many health care professionals and pharmaceutical and medical device executives. So, for the past few years,

Competitive Intelligence Guidelines & Policies Keeping Companies in the Safety Zone

Competitive Intelligence (CI) groups are instrumental in helping world-class companies to anticipate and respond strategically to external change. Primary and secondary competitive intelligence research helps organizations to improve their chances for success in today’s competitive business environment. While there are

Best Practices in Structuring & Staffing Pharma Government Affairs’ Groups

The Government Affairs and Public Policy functions play an important role in the Pharmaceutical industry. Both functions are involved in critical areas such as legislative affairs, reimbursement, and regulatory, making it essential for organizations to have not only appropriate staffing

Pharmaceutical Giants Pioneering the Way in Social Media

A recent article featured on FiercePharma’s website offers a list of the leading pharmaceutical companies in the social media arena. The article, “Top 10 pharma companies in social media,” lists pharmaceutical giants Johnson & Johnson, GlaxoSmithKline, and Novo Nordisk as

Top 5 Best Practices in Avoiding Regulatory Risk in Digital Marketing

More than ever, patients and physicians are utilizing social media and online web portals to find treatment answers to their conditions. As traditional marketing diminishes and social media continues to flourish, leaders in the healthcare industry must find new ways

Best Practices in Delivering MSL Services to Diverse Customer Groups

Biopharmaceutical & Medical Device companies often struggle with the challenge of delivering exceptional services to a diverse set of customers. On top of this, concerns about compliance and legal limitations are forcing companies to re-examine how their medical science liaisons